Abdullatif Khedr-Al

Amiens, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Journal: CNS drugs
Published: September 04, 2025

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

Journal: JAMA neurology
Published: August 04, 2025

Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life Study.

Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life Study.

Journal: Neurology
Published: September 25, 2024

Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.

Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.

Journal: JAMA neurology
Published: July 01, 2024

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.

Journal: JAMA neurology
Published: March 25, 2024

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

Journal: BMC medical research methodology
Published: January 14, 2022

The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.

The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.

Journal: Multiple sclerosis and related disorders
Published: January 31, 2021

Untreated patients with multiple sclerosis: A study of French expert centers.

Untreated patients with multiple sclerosis: A study of French expert centers.

Journal: European journal of neurology
Published: January 17, 2021

Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.

Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.

Journal: JAMA neurology
Published: September 04, 2019
Showing 1-9 of 9

Last Updated: 09/26/2026